Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the

Eliz Arnavut1, John Hamilton1, Rutao Yao2

  • 1Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Department of Pharmacology and Toxicology, Clinical Research Institute on Addictions, Jacobs School of Medicine and Biomedical Sciences, State University at Buffalo, Buffalo, New York.

Insights

Chronic methylphenidate (MP) use did not alter brain glucose metabolism in rats. However, abstinence from MP revealed significant metabolic changes in brain regions involved in sensory and motor functions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Imaging

Background:

  • Methylphenidate (MP) is a psychostimulant commonly prescribed for Attention Deficit Hyperactivity Disorder (ADHD).
  • Patients may take intermittent breaks from MP, termed 'drug holidays,' involving short or long-term cessation.
  • Understanding MP's effects on brain metabolism during continuous use and abstinence is crucial due to its widespread prescription and off-label use.

Purpose of the Study:

  • To investigate the impact of chronic oral methylphenidate (MP) administration and subsequent abstinence on brain glucose metabolism (BGluM) in rats.
  • To assess dose-dependent effects of MP on BGluM using high dose (HD) and low dose (LD) regimens.
  • To explore the influence of a specific treatment schedule (3 weeks on, 1 week off) on brain metabolic activity.

Main Methods:

  • Utilized fluorodeoxyglucose (FDG) positron emission tomography (PET) to measure BGluM in Sprague-Dawley rats.
  • Administered MP orally following a cyclical schedule: 3 weeks of treatment followed by 1 week off, repeated for 13 weeks.
  • Conducted a 4-week abstinence period post-treatment to evaluate metabolic recovery and changes.

Main Results:

  • Chronic MP treatment, even at a high dose, did not induce significant changes in overall BGluM compared to control rats.
  • Significant increases in BGluM were observed in specific brain regions after the abstinence period in HD MP rats versus controls.
  • Affected regions included the trigeminal nucleus, reticular nucleus, inferior olive, lemniscus, mesencephalic reticular formation, inferior colliculus, and cerebellum, involved in sensory, auditory, motor, and cognitive functions.

Conclusions:

  • The schedule and dose of methylphenidate (MP) significantly influence brain glucose metabolism (BGluM) during abstinence, not necessarily during continuous use.
  • MP's long-term effects on BGluM are complex and depend on the dosing regimen and intermittent cessation.
  • Further research is warranted to elucidate MP's effects in ADHD models and understand the long-term implications of its varied usage patterns.